600
Participants
Start Date
November 30, 2006
Study Completion Date
October 31, 2007
[S,S]-Reboxetine
Pfizer Investigational Site, Split
Pfizer Investigational Site, Greensboro
Pfizer Investigational Site, Ourense
Pfizer Investigational Site, West Palm Beach
Pfizer Investigational Site, Tampa
Pfizer Investigational Site, Panevezys
Pfizer Investigational Site, Kaunas
Pfizer Investigational Site, Fargo
Pfizer Investigational Site, Šiauliai
Pfizer Investigational Site, San Antonio
Pfizer Investigational Site, Klaipėda
Pfizer Investigational Site, Mérida
Pfizer Investigational Site, Viña del Mar
Pfizer Investigational Site, Cumberland
Pfizer Investigational Site, Buenos Aires
Pfizer Investigational Site, Buenos Aires
Pfizer Investigational Site, Buenos Aires
Pfizer Investigational Site, Buenos Aires
Pfizer Investigational Site, Greater Sudbury
Pfizer Investigational Site, Greater Sudbury
Pfizer Investigational Site, Greater Sudbury
Pfizer Investigational Site, Toronto
Pfizer Investigational Site, Montreal
Pfizer Investigational Site, Santiago
Pfizer Investigational Site, Hyderabad
Pfizer Investigational Site, Hyderabad
Pfizer Investigational Site, Chandigarh
Pfizer Investigational Site, Bangalore
Pfizer Investigational Site, Chennai
Pfizer Investigational Site, New Delhi
Pfizer Investigational Site, New Delhi
Pfizer Investigational Site, Sopot
Pfizer Investigational Site, Stockholm
Pfizer Investigational Site, Bexhill-on-Sea
Pfizer Investigational Site, Addlestone
Pfizer Investigational Site, Alcester
Pfizer Investigational Site, East Sussex
Pfizer Investigational Site, London
Pfizer Investigational Site, London
Pfizer Investigational Site, London
Lead Sponsor
Pfizer
INDUSTRY